The OpenZone drug discovery unit will be used to support Enthera’s new discovery program and accelerate its mission to identify new treatments for intractable autoimmune diseases Milan, Italy, 7 July 2021 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing first-in-class biologics for selected autoimmune conditions based on the discovery of a novel apoptosis pathway, today […]
This author has not written his bio yet.
But we are proud to say that hearten contributed 17 entries already.
Entries by hearten
Milan, Italy, 1 April 2021 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing novel disease-modifying biologics that re-establish stem cell capabilities to treat specific autoimmune diseases, today announces the appointment of Claudia Nardini as Vice President of Research and Development to support the Company’s manufacturing and regulatory divisions. Claudia has 25 years of experience in […]
The Company Enthera (www.entherapharmaceuticals.com) is a biotech company building a pipeline of first-in-class biologics for several underserved autoimmune conditions, with a focus on Type 1 Diabetes (T1D) and Inflammatory Bowel Disease (IBD). Our aim is to develop disease-modifying treatments by preserving and re-establishing cell and organ function to revert the outcome of these conditions. treatment. […]
The Roche Venture Fund joins international investor syndicate, including co-lead investors Sofinnova Partners and AbbVie Ventures Funds to be used to advance restorative therapy for type 1 diabetes and inflammatory bowel disease Largest international VC-backed Series A financing round for a biotech in Italy to date and first ever venture investment in an Italian company […]
Milan, Italy, 3 December 2020 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing disease-modifying biologics to transform the therapeutic paradigm of specific autoimmune conditions by re-establishing stem cell capabilities in a non-traditional way, announces that it has appointed Kazumi Shiosaki to its Board of Directors, and Lisa Olson to its Scientific Advisory Board.
Milan, Italy – Enthera Pharmaceuticals (“Enthera”), a biotech company developing disease-modifying biologics to transform the therapeutic paradigm of specific autoimmune conditions by re-establishing stem cell capabilities in a non-traditional way, today announces the completion of a €28 million Series A financing round.
Director of Regulatory Affairs Job Description This position will lead the regulatory strategy for all the products in the pipeline. She/he will be responsible of multiple innovative global regulatory strategies for product development and approval. Responsible for defining strategies, for regulatory documents, submissions, and compliance issues. Represent the company with all international regulatory authorities, reporting […]
Chief Financial Officer Job Description This position will have a broad range of responsibilities serving as Finance lead delivering solid financial controlling support to senior leaders. Reporting to the Chief Executive Officer, the Financial Director is a critical role intended to encompass activities related to budgeting, forecasting, analysis and reporting to support the corporation’s leadership team […]
JP Morgan Meeting San Francisco, USA 13-17 January 2020
Project Manager – Chemistry Manufacturing and Control (CMC) Job Description The CMC Project Manager will support planning, tracking and communication of CMC activities to both internal and external stakeholders and partners, including designated Contract Manufacturing Organizations (CMOs). Facilitate CMC related meetings, maintain CMC project schedules and ensure alignment with cross-functional integrated timelines. Responsibilities Utilize project […]